CCR plots new path for CCR Re, willing to sell €200m stake to ‘new shareholder’
French government-backed CCR has plotted a new course for CCR Re, writing reinsurance in the private international markets, in a move aimed at driving profitable growth at its subsidiary while raising fresh capital and steering away its ownership from being a state-controlled carrier.
CCR’s board of directors have passed a set of resolutions in line with its strategic plan introduced in 2021, aiming to refocus its business activity and strengthen its resources in public-sector reinsurance, particularly with a view to dealing with the challenges that lie ahead, such as insurance for natural disasters.
The board is willing to sell, by July 2023, a €200 million stake in CCR Re to a “new shareholder” (or group of shareholders) as part of a capital increase, which will result in holding a majority stake in the market subsidiary.
The transaction will be part of the process of separating CCR’s market activities from its public-sector activities, the company’s top officials have declared. It will also allow CCR Re to reach the “critical size and level of profitability” it needs to self-finance its growth in line with market rates.
Under the business plan adopted by CCR Re, it will therefore seek to write €2 billion in gross premiums by 2027, with a 10% profitability, the company said.
To support these strategic initiatives and CCR’s ambitions in relation to public-sector reinsurance, the company’s board has also decided to strengthen CCR’s executive management team and approved the appointment of Edouard Vieillefond as deputy chief executive officer, alongside Bertrand Labilloy, who remains chief executive officer of CCR and chairman and chief executive officer of CCR Re.
Jacques Le Pape, chairman of CCR’s board of directors, said: “We are going to provide CCR Re with the resources it needs to grow and become autonomous. This will allow CCR to strengthen its public-sector activities, at a time when natural disasters are becoming more frequent and more intense.”
Did you get value from this story? Sign up to our free daily newsletters and get stories like this sent straight to your inbox.
Already registered?
Login to your account
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Elliot Field at efield@newtonmedia.co.uk or Adrian Tapping at atapping@newtonmedia.co.uk
Editor's picks
Editor's picks
More articles
Copyright © intelligentinsurer.com 2024 | Headless Content Management with Blaze